Federal contract award

W911SR25CA011

THIS EFFORT IS TO DEMONSTRATE THE FEASIBILITY AND EFFICACY OF BREAKTHROUGH RAPID ROOM-TEMPERATURE AEROSOL DEHYDRATION (RTAD) TECHNOLOGY FOR PRODUCING SHELF-STABLE, BIOACTIVE POWDERS WITH CONTROLLABLE NANOPARTICLE MORPHOLOGY

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeW6QK ACC-APG
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeFIRM FIXED PRICE
Obligations$209.6K
Current contract value$209.6K
Potential contract value / ceiling$209.6K
Start dateJul 29, 2025
Current end dateJan 28, 2026
Potential end dateJan 28, 2026
Latest award activityJul 29, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 29, 20250$209.6KTHIS EFFORT IS TO DEMONSTRATE THE FEASIBILITY AND EFFICACY OF BREAKTHROUGH RAPID ROOM-TEMPERATURE AEROSOL DEHYDRATION (RTAD) TECHNOLOGY FOR PRODUCING SHELF-STABLE, BIOACTIVE POWDERS WITH CONTROLLABLE NANOPARTICLE MORPHOLOGY

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.